BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 31435168)

  • 1. Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases.
    Yoo JH; Donowitz M
    World J Gastroenterol; 2019 Aug; 25(30):4125-4147. PubMed ID: 31435168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organoid Medicine for Inflammatory Bowel Disease.
    Wakisaka Y; Sugimoto S; Sato T
    Stem Cells; 2022 Mar; 40(2):123-132. PubMed ID: 35258629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Human Induced Pluripotent Stem Cell-Derived Intestinal Organoids as a Model of Epithelial Damage and Fibrosis in Inflammatory Bowel Disease.
    Onozato D; Akagawa T; Kida Y; Ogawa I; Hashita T; Iwao T; Matsunaga T
    Biol Pharm Bull; 2020; 43(7):1088-1095. PubMed ID: 32612071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteroids Derived From Inflammatory Bowel Disease Patients Display Dysregulated Endoplasmic Reticulum Stress Pathways, Leading to Differential Inflammatory Responses and Dendritic Cell Maturation.
    Rees WD; Stahl M; Jacobson K; Bressler B; Sly LM; Vallance BA; Steiner TS
    J Crohns Colitis; 2020 Jul; 14(7):948-961. PubMed ID: 31796949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.
    Howell KJ; Kraiczy J; Nayak KM; Gasparetto M; Ross A; Lee C; Mak TN; Koo BK; Kumar N; Lawley T; Sinha A; Rosenstiel P; Heuschkel R; Stegle O; Zilbauer M
    Gastroenterology; 2018 Feb; 154(3):585-598. PubMed ID: 29031501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
    Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
    Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease.
    Okamoto R; Watanabe M
    J Gastroenterol; 2016 Jan; 51(1):11-21. PubMed ID: 26138071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived organoids for therapy personalization in inflammatory bowel diseases.
    Lucafò M; Muzzo A; Marcuzzi M; Giorio L; Decorti G; Stocco G
    World J Gastroenterol; 2022 Jun; 28(24):2636-2653. PubMed ID: 35979165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease.
    Lloyd K; Papoutsopoulou S; Smith E; Stegmaier P; Bergey F; Morris L; Kittner M; England H; Spiller D; White MHR; Duckworth CA; Campbell BJ; Poroikov V; Martins Dos Santos VAP; Kel A; Muller W; Pritchard DM; Probert C; Burkitt MD;
    Dis Model Mech; 2020 Nov; 13(11):. PubMed ID: 32958515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
    Chiriac MT; Buchen B; Wandersee A; Hundorfean G; Günther C; Bourjau Y; Doyle SE; Frey B; Ekici AB; Büttner C; Weigmann B; Atreya R; Wirtz S; Becker C; Siebler J; Neurath MF
    Gastroenterology; 2017 Jul; 153(1):123-138.e8. PubMed ID: 28342759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms and regulation of IL-22-mediated intestinal epithelial homeostasis and repair.
    Patnaude L; Mayo M; Mario R; Wu X; Knight H; Creamer K; Wilson S; Pivorunas V; Karman J; Phillips L; Dunstan R; Kamath RV; McRae B; Terrillon S
    Life Sci; 2021 Apr; 271():119195. PubMed ID: 33581125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Use of Human Stem Cell-Derived Intestinal Organoids to Study Inflammatory Bowel Diseases.
    Dotti I; Salas A
    Inflamm Bowel Dis; 2018 Nov; 24(12):2501-2509. PubMed ID: 30169820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human colon organoids from healthy and inflammatory bowel disease mucosa.
    Dotti I; Mayorgas A; Salas A
    PLoS One; 2022; 17(10):e0276195. PubMed ID: 36301950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation.
    Wong J; Garcia-Carbonell R; Zelic M; Ho SB; Boland BS; Yao SJ; Desai SA; Das S; Planell N; Harris PA; Font-Burgada J; Taniguchi K; Bertin J; Salas A; Pasparakis M; Gough PJ; Kelliher M; Karin M; Guma M
    Cell Mol Gastroenterol Hepatol; 2020; 9(2):295-312. PubMed ID: 31606566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.
    Lie MRKL; van der Giessen J; Fuhler GM; de Lima A; Peppelenbosch MP; van der Ent C; van der Woude CJ
    J Transl Med; 2018 Mar; 16(1):55. PubMed ID: 29523156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Application of Intestinal Organoids in Intestinal Diseases.
    Liu W; Wang Q; Bai Y; Xiao H; Li Z; Wang Y; Wang Q; Yang J; Sun H
    Stem Cell Rev Rep; 2024 Jan; 20(1):124-137. PubMed ID: 37938407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD.
    Hartwig O; Shetab Boushehri MA; Shalaby KS; Loretz B; Lamprecht A; Lehr CM
    Adv Drug Deliv Rev; 2021 Aug; 175():113828. PubMed ID: 34157320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier.
    Jelinsky SA; Derksen M; Bauman E; Verissimo CS; van Dooremalen WTM; Roos JL; Higuera Barón C; Caballero-Franco C; Johnson BG; Rooks MG; Pott J; Oldenburg B; Vries RGJ; Boj SF; Kasaian MT; Pourfarzad F; Rosadini CV
    Inflamm Bowel Dis; 2023 Feb; 29(2):195-206. PubMed ID: 36356046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.